{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:11Z","timestamp":1740107711228,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:00:00Z","timestamp":1535155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773460"],"award-info":[{"award-number":["81773460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20161609"],"award-info":[{"award-number":["BK20161609"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10067-018-4273-1","type":"journal-article","created":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T07:28:05Z","timestamp":1535182085000},"page":"2887-2891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The benchmark dose estimation of reference levels of serum urate for gout"],"prefix":"10.1007","volume":"37","author":[{"given":"Xiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongqiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,25]]},"reference":[{"issue":"10","key":"4273_CR1","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 63(10):3136\u20133141","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4273_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41584-018-0004-x","volume":"14","author":"TJ Major","year":"2018","unstructured":"Major TJ, Dalbeth N, Stahl EA, Merriman TR (2018) An update on the genetics of hyperuricaemia and gout. Nat Rev Rheumatol 14(6):341\u2013353","journal-title":"Nat Rev Rheumatol"},{"key":"4273_CR3","doi-asserted-by":"publisher","unstructured":"Pascart T, Liot\u00e9 F (2018) Gout: state of the art after a decade of developments. Rheumatology (Oxford). \n                    https:\/\/doi.org\/10.1093\/rheumatology\/key002","DOI":"10.1093\/rheumatology\/key002"},{"key":"4273_CR4","volume-title":"The epidemiology of chronic rheumatism","author":"J Kellgren","year":"1963","unstructured":"Kellgren J, Jeffrey MR, Ball J (1963) The epidemiology of chronic rheumatism. Blackwell Scientific Publications, Oxford"},{"issue":"2","key":"4273_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/BOR.0000000000000028","volume":"26","author":"T Bardin","year":"2014","unstructured":"Bardin T, Richette P (2014) Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol 26(2):186\u2013191","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"4273_CR6","doi-asserted-by":"publisher","first-page":"e014928","DOI":"10.1136\/bmjopen-2016-014928","volume":"7","author":"Q Li","year":"2017","unstructured":"Li Q, Li X, Kwong JS et al (2017) Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements. BMJ Open 7(6):e014928","journal-title":"BMJ Open"},{"issue":"3","key":"4273_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jbspin.2015.01.002","volume":"82","author":"T Bardin","year":"2015","unstructured":"Bardin T (2015) Hyperuricemia starts at 360 micromoles (6 mg\/dL). Joint Bone Spine 82(3):141\u2013143","journal-title":"Joint Bone Spine"},{"issue":"7","key":"4273_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","volume":"143","author":"HK Choi","year":"2005","unstructured":"Choi HK, Mount DB, Reginato AM (2005) Pathogenesis of gout. Ann Intern Med 143(7):499\u2013516","journal-title":"Ann Intern Med"},{"issue":"5","key":"4273_CR9","first-page":"505","volume":"33","author":"AF Filipsson","year":"2003","unstructured":"Filipsson AF, Sand S, Nilsson J, Victorin K (2003) The benchmark dose method-review of available models, and recommendations for application in health risk assessment. Crit Rev Toxicol 33(5):505\u2013542","journal-title":"Crit Rev Toxicol"},{"issue":"5","key":"4273_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1289\/ehp.1307539","volume":"122","author":"JA Wignall","year":"2014","unstructured":"Wignall JA, Shapiro AJ, Wright FA, Woodruff TJ, Chiu WA, Guyton KZ, Rusyn I (2014) Standardizing benchmark dose calculations to improve science-based decisions in human health assessments. Environ Health Perspect 122(5):499\u2013505","journal-title":"Environ Health Perspect"},{"issue":"1","key":"4273_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1539-6924.1995.tb00095.x","volume":"15","author":"KS Crump","year":"1995","unstructured":"Crump KS (1995) Calculation of benchmark doses from continuous data. Risk Anal 15(1):79\u201389","journal-title":"Risk Anal"},{"issue":"1","key":"4273_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/toxsci\/kfj057","volume":"90","author":"S Sand","year":"2006","unstructured":"Sand S, von Rosen D, Victorin K, Falk Filipsson A (2006) Identification of a critical dose level for risk assessment: developments in benchmark dose analysis of continuous endpoints. Toxicol Sci 90(1):241\u2013251","journal-title":"Toxicol Sci"},{"issue":"5","key":"4273_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/10408444.2018.1430121","volume":"48","author":"LT Haber","year":"2018","unstructured":"Haber LT, Dourson ML, Allen BC, Hertzberg RC, Parker A, Vincent MJ, Maier A, Boobis AR (2018) Benchmark dose (BMD) modeling: current practice, issues, and challenges. Crit Rev Toxicol 48(5):387\u2013415","journal-title":"Crit Rev Toxicol"},{"key":"4273_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.alcohol.2016.08.002","volume":"56","author":"T Makinouchi","year":"2016","unstructured":"Makinouchi T, Sakata K, Oishi M, Tanaka K, Nogawa K, Watanabe M, Suwazono Y (2016) Benchmark dose of alcohol consumption for development of hyperuricemia in Japanese male workers: an 8-year cohort study. Alcohol 56:9\u201314","journal-title":"Alcohol"},{"issue":"7","key":"4273_CR15","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","volume":"77","author":"N Dalbeth","year":"2018","unstructured":"Dalbeth N, Phipps-Green A, Frampton C, Neogi T, Taylor WJ, Merriman TR (2018) Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis. Ann Rheum Dis 77(7):1048\u20131052","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4273_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.etap.2014.11.026","volume":"39","author":"X Chen","year":"2015","unstructured":"Chen X, Wang Z, Zhu G, Liang Y, Jin T (2015) Benchmark dose estimation of cadmium reference level for hypertension in a Chinese population. Environ Toxcicol Pharmacol 39(1):208\u2013212","journal-title":"Environ Toxcicol Pharmacol"},{"issue":"2","key":"4273_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10067-011-1802-6","volume":"31","author":"JH Chen","year":"2012","unstructured":"Chen JH, Yeh WT, Chuang SY, Wu YY, Pan WH (2012) Gender-specific risk factors for incident gout: a prospective cohort study. Clin Rheumatol 31(2):239\u2013245","journal-title":"Clin Rheumatol"},{"issue":"2","key":"4273_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/art.1780150209","volume":"15","author":"JN Loeb","year":"1972","unstructured":"Loeb JN (1972) The influence of temperature on the solubility of monosodium urate. Arthritis Rheum 15(2):189\u2013192","journal-title":"Arthritis Rheum"},{"issue":"8","key":"4273_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/ard.50.8.558","volume":"50","author":"NW McGill","year":"1991","unstructured":"McGill NW, Dieppe PA (1991) Evidence for a promoter of urate crystal formation in gouty synovial fluid. Ann Rheum Dis 50(8):558\u2013561","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4273_CR20","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/art.27338","volume":"62","author":"V Bhole","year":"2010","unstructured":"Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H (2010) Epidemiology of gout in women: fifty-two-year followup of a prospective cohort. Arthritis Rheum 62(4):1069\u20131076","journal-title":"Arthritis Rheum"},{"issue":"10","key":"4273_CR21","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Liot\u00e9 F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R, American College of Rheumatology (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res 64(10):1431\u20131446","journal-title":"Arthritis Care Res"},{"issue":"1","key":"4273_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Casta\u00f1eda-Sanabria J, Coyfish M, Guillo S, Jansen TL, Janssens H, Liot\u00e9 F, Mallen C, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell T, So A, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76(1):29\u201342","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"4273_CR23","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","volume":"46","author":"KM Jordan","year":"2007","unstructured":"Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, Hingorani A, Jaques R, Nuki G, British Society for Rheumatology and British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group (SGAWG) (2007) British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology 46(8):1372\u20131374","journal-title":"Rheumatology"},{"key":"4273_CR24","doi-asserted-by":"publisher","unstructured":"Abhishek A, Courtney P, Jenkins W, Sandoval-Plata G, Jones AC, Zhang W, Doherty M (2018) Monosodium urate crystal deposits are common in asymptomatic sons of people with gout-The Sons of gout study. Arthritis Rheumatol. \n                    https:\/\/doi.org\/10.1002\/art.40572","DOI":"10.1002\/art.40572"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4273-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4273-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4273-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T19:45:56Z","timestamp":1569008756000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4273-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,25]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["4273"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4273-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2018,8,25]]},"assertion":[{"value":"8 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by the ethics committee of the Affiliated Hospital of Nanjing University of Chinese Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}